Bexson Biomedical is developing a unique formulation of ketamine for chronic and acute pain disorders. Founded in 2016, Bexson Biomedical is backed by investors that include Noetic Fund and is headquartered in Santa Barbara.
FOUNDED:
2016
INDUSTRY:
Health Care, Pharmaceutical
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
